Hyalinizing trabecular carcinoma of thyroid gland

1996 ◽  
Vol 28 (4) ◽  
pp. 357-362 ◽  
Author(s):  
W.G. McCLUGGAGE ◽  
J.M. SLOAN
2008 ◽  
Vol 52 (4) ◽  
pp. 529-531 ◽  
Author(s):  
S Gowrishankar ◽  
S A Pai ◽  
J A Carney

1994 ◽  
Vol 25 (2) ◽  
pp. 192-197 ◽  
Author(s):  
Kyle Molberg ◽  
Jorge Albores-Saavedra

1998 ◽  
Vol 22 (1) ◽  
pp. 39-46 ◽  
Author(s):  
Ricardo González-cámpora ◽  
Elena Fuentes-Vaamonde ◽  
Alberto Hevia-vázquez ◽  
Concepción Otal-Salaverri ◽  
Jose Luis Villar-Rodriguez ◽  
...  

1972 ◽  
Vol 105 (1) ◽  
pp. 107-110 ◽  
Author(s):  
C. Toker
Keyword(s):  

JAMA ◽  
1967 ◽  
Vol 200 (2) ◽  
pp. 178-179 ◽  
Author(s):  
G. D. Skalkeas
Keyword(s):  

2015 ◽  
Vol 122 (03) ◽  
Author(s):  
M Ehlers ◽  
S Allelein ◽  
A Kuebart ◽  
T Dringenberg ◽  
M Haase ◽  
...  
Keyword(s):  

1981 ◽  
Vol 20 (02) ◽  
pp. 72-75 ◽  
Author(s):  
R. Kocak ◽  
R.G. Herbert ◽  
C.R. Squire ◽  
T.M.D. Gimlette

Radioiodine in the thyroid gland after a therapy dose of 131I was measured serially in 7 patients without Carbimazole, and in 11 patients starting Carbimazole 60 mg daily fourteen days after the therapy dose. Effective half-life for radioiodine in the gland initially 5.53±1.08 days fell to 4.26±1.12 days (p < 0.01) during Carbimazole, and returned to 5.83±1.21 days (NS) after stopping the drug. The radiation dose to the thyroid from a given therapy dose of 131I followed by Carbimazole was calculated to be 97% of that without Carbimazole when the drug was started after 14 days, and 90% and 75% when the drug was started after 7 days and 1 day respectively.


Sign in / Sign up

Export Citation Format

Share Document